{"transactions":[{"id":1467252,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-28T20:53:49.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":2.38,"value":9520.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 20, 2024, the Reporting Person received a grant of 4,000 stock options from the Issuer. One-half vested immediately, one-fourth will vest on September 30, 2024 and one-fourth will vest on December 31, 2024."}],"balance_after":7067,"derivative":{"exercise_price":2.38,"expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001493152-24-025692","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740988/000149315224025692/ownership.xml","form_type":"4"}},{"id":2075531,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-28T21:45:42.000Z","date":"2022-12-23","kind":"grant","acquired":true,"shares":30000,"price":0.48,"value":14400.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"30,000 stock options granted on December 23, 2022. One-half vested immediately and one-eighth vests quarterly every three months through December 23, 2023."}],"balance_after":76667,"derivative":{"exercise_price":0.48,"expiration_date":"2027-12-23","underlying":"Common Stock","underlying_shares":76667},"source":{"system":"sec-edgar","filing":"0001493152-22-036725","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740988/000149315222036725/ownership.xml","form_type":"4"}},{"id":2608579,"issuer":{"id":8396,"kind":"organization","name":"Vivos Therapeutics, Inc."},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-10T21:49:17.000Z","date":"2021-08-05","kind":"grant","acquired":true,"shares":30000,"price":2.72,"value":81600.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"30,000 stock options granted on August 5, 2021. One-half vested immediately and one-eighth vests quarterly every three months through August 5, 2022."}],"balance_after":46667,"derivative":{"exercise_price":2.72,"expiration_date":"2026-08-05","underlying":"Common Stock","underlying_shares":46667},"source":{"system":"sec-edgar","filing":"0001493152-21-019258","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740988/000149315221019258/ownership.xml","form_type":"4"}},{"id":3057682,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-08-14T18:47:44.000Z","date":"2020-08-12","kind":"sale","acquired":false,"shares":21888,"price":0.088,"value":1926.144,"ownership":{"direct":true},"balance_after":52878,"source":{"system":"sec-edgar","filing":"0001013606-20-000167","document":"wf-form4_159744525010993.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360620000167/wf-form4_159744525010993.xml","form_type":"4"}},{"id":3065105,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-08-07T20:09:58.000Z","date":"2020-08-05","kind":"disposition_to_issuer","acquired":false,"shares":3417,"price":0.0698,"value":238.5066,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld on August 5, 2020 to satisfy statutory minimum tax withholding obligations related to shares vested on August 5, 2020."}],"balance_after":74766,"source":{"system":"sec-edgar","filing":"0001013606-20-000144","document":"wf-form4_159684534736856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360620000144/wf-form4_159684534736856.xml","form_type":"4"}},{"id":3065104,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-08-07T20:09:58.000Z","date":"2020-08-05","kind":"disposition_to_issuer","acquired":true,"shares":30433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on August 6, 2019. One-third of the shares subject to this restricted stock unit award vested pursuant to the terms of this award."}],"balance_after":78183,"source":{"system":"sec-edgar","filing":"0001013606-20-000144","document":"wf-form4_159684534736856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360620000144/wf-form4_159684534736856.xml","form_type":"4"}},{"id":3292718,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-04T16:04:51.000Z","date":"2020-01-31","kind":"tax_withholding","acquired":false,"shares":783,"price":1,"value":783.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld on January 31, 2020 to satisfy statutory minimum tax withholding obligations related to shares vested on January 31, 2020."}],"balance_after":78183,"source":{"system":"sec-edgar","filing":"0001013606-20-000013","document":"wf-form4_158085027328404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360620000013/wf-form4_158085027328404.xml","form_type":"4"}},{"id":3292717,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-04T16:04:51.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":1914,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on February 1, 2019. 100% of the shares subject to this restricted stock unit award vested pursuant to the terms of this award."}],"balance_after":78966,"source":{"system":"sec-edgar","filing":"0001013606-20-000013","document":"wf-form4_158085027328404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360620000013/wf-form4_158085027328404.xml","form_type":"4"}},{"id":3327897,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-01-02T16:20:37.000Z","date":"2019-12-30","kind":"tax_withholding","acquired":false,"shares":5278,"price":1.68,"value":8867.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld on December 30, 2019 to satisfy statutory minimum tax withholding obligations related to shares vested on December 30, 2019."}],"balance_after":78966,"source":{"system":"sec-edgar","filing":"0001013606-20-000006","document":"wf-form4_157800002042354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360620000006/wf-form4_157800002042354.xml","form_type":"4"}},{"id":3327896,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-01-02T16:20:37.000Z","date":"2019-12-30","kind":"grant","acquired":true,"shares":47011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on January 2, 2019. One third of the shares subject to this restricted stock unit award vested pursuant to the terms of this award."}],"balance_after":84244,"source":{"system":"sec-edgar","filing":"0001013606-20-000006","document":"wf-form4_157800002042354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360620000006/wf-form4_157800002042354.xml","form_type":"4"}},{"id":3403537,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to Purchase","published_at":"2019-10-01T16:30:31.000Z","date":"2019-09-27","kind":"grant","acquired":true,"shares":6304,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The options vest in three equal annual installments over a three-year period commencing on September 10, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The issuer cancelled, pursuant to the issuer's option exchange program which expired on September 9, 2019, (i) an option for 8,999 shares of common stock granted to the reporting person on May 31, 2017, and (ii) an option for 9,907 shares of common stock granted to the reporting person on December 1, 2016.  In exchange, the reporting person received a new stock option, for 6,304 shares, having an exercise price of $4.71 per share, which is equal to the closing price per share of the common stock on the NASDAQ Global Market on September 10, 2019."}],"balance_after":6304,"derivative":{"exercise_price":4.71,"exercise_date":"2020-09-10","expiration_date":"2026-09-10","underlying":"Common Stock","underlying_shares":6304},"source":{"system":"sec-edgar","filing":"0001013606-19-000169","document":"wf-form4_156996180819122.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000169/wf-form4_156996180819122.xml","form_type":"4"}},{"id":3403536,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to Purchase","published_at":"2019-10-01T16:30:31.000Z","date":"2019-09-27","kind":"disposition_to_issuer","acquired":false,"shares":9907,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Twenty-five percent of the options vested upon one year of service and the remaining balance continued to vest in equal monthly installments thereafter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The issuer cancelled, pursuant to the issuer's option exchange program which expired on September 9, 2019, (i) an option for 8,999 shares of common stock granted to the reporting person on May 31, 2017, and (ii) an option for 9,907 shares of common stock granted to the reporting person on December 1, 2016.  In exchange, the reporting person received a new stock option, for 6,304 shares, having an exercise price of $4.71 per share, which is equal to the closing price per share of the common stock on the NASDAQ Global Market on September 10, 2019."}],"balance_after":0,"derivative":{"exercise_price":69.1,"exercise_date":"2017-12-01","expiration_date":"2026-12-01","underlying":"Common Stock","underlying_shares":9907},"source":{"system":"sec-edgar","filing":"0001013606-19-000169","document":"wf-form4_156996180819122.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000169/wf-form4_156996180819122.xml","form_type":"4"}},{"id":3403535,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to Purchase","published_at":"2019-10-01T16:30:31.000Z","date":"2019-09-27","kind":"disposition_to_issuer","acquired":false,"shares":8999,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Options vest ratably over forty-eight months."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The issuer cancelled, pursuant to the issuer's option exchange program which expired on September 9, 2019, (i) an option for 8,999 shares of common stock granted to the reporting person on May 31, 2017, and (ii) an option for 9,907 shares of common stock granted to the reporting person on December 1, 2016.  In exchange, the reporting person received a new stock option, for 6,304 shares, having an exercise price of $4.71 per share, which is equal to the closing price per share of the common stock on the NASDAQ Global Market on September 10, 2019."}],"balance_after":0,"derivative":{"exercise_price":48.2,"exercise_date":"2017-06-30","expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":8999},"source":{"system":"sec-edgar","filing":"0001013606-19-000169","document":"wf-form4_156996180819122.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000169/wf-form4_156996180819122.xml","form_type":"4"}},{"id":3445916,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to Purchase","published_at":"2019-08-06T17:15:35.000Z","date":"2019-08-05","kind":"grant","acquired":true,"shares":60867,"price":6.67,"value":405982.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Options vest ratably over thirty-six months."}],"balance_after":60867,"derivative":{"exercise_price":6.67,"exercise_date":"2019-09-05","expiration_date":"2029-08-05","underlying":"Common Stock","underlying_shares":60867},"source":{"system":"sec-edgar","filing":"0001013606-19-000132","document":"wf-form4_156512611903617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000132/wf-form4_156512611903617.xml","form_type":"4"}},{"id":3445915,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-08-06T17:15:35.000Z","date":"2019-08-05","kind":"grant","acquired":true,"shares":30433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Performance restricted stock unit award based on predetermined goals."}],"balance_after":84244,"source":{"system":"sec-edgar","filing":"0001013606-19-000132","document":"wf-form4_156512611903617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000132/wf-form4_156512611903617.xml","form_type":"4"}},{"id":3532157,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-05-10T17:50:01.000Z","date":"2019-05-08","kind":"tax_withholding","acquired":false,"shares":421,"price":6.4,"value":2694.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld on May 8, 2019 to satisfy statutory minimum tax withholding obligations related to shares vested on May 8, 2019."}],"balance_after":53811,"source":{"system":"sec-edgar","filing":"0001013606-19-000094","document":"wf-form4_155752498602058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000094/wf-form4_155752498602058.xml","form_type":"4"}},{"id":3532156,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-05-10T17:50:01.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award was originally reported on a Form 3 filed with the Securities and Exchange Commission on June 1, 2018. 50% of the shares subject to this restricted stock award vested pursuant to the terms of this award."}],"balance_after":54232,"source":{"system":"sec-edgar","filing":"0001013606-19-000094","document":"wf-form4_155752498602058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000094/wf-form4_155752498602058.xml","form_type":"4"}},{"id":3680093,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-01T16:03:54.000Z","date":"2019-01-31","kind":"grant","acquired":true,"shares":19142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the time-based restricted stock unit award shall vest on January 31, 2020 and shall settle in shares of common stock."}],"balance_after":542319,"source":{"system":"sec-edgar","filing":"0001013606-19-000029","document":"wf-form4_154905501691166.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000029/wf-form4_154905501691166.xml","form_type":"4"}},{"id":3714705,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to Purchase","published_at":"2019-01-02T21:03:28.000Z","date":"2018-12-30","kind":"grant","acquired":true,"shares":225621,"price":0.7445,"value":167974.8345,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"100% of the option award shall vest on December 30, 2019."}],"balance_after":225621,"derivative":{"exercise_price":0.7445,"exercise_date":"2019-12-30","expiration_date":"2028-12-30","underlying":"Common Stock","underlying_shares":225621},"source":{"system":"sec-edgar","filing":"0001013606-19-000022","document":"wf-form4_154648099216564.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000022/wf-form4_154648099216564.xml","form_type":"4"}},{"id":3714704,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-02T21:03:28.000Z","date":"2018-12-30","kind":"grant","acquired":true,"shares":470115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The time-based restricted stock unit award shall vest in three equal annual installments on December 30, 2019, December 30, 2020 and December 30, 2021 and shall settle in shares of common stock on each of those dates."}],"balance_after":523177,"source":{"system":"sec-edgar","filing":"0001013606-19-000022","document":"wf-form4_154648099216564.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000022/wf-form4_154648099216564.xml","form_type":"4"}},{"id":3714703,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-02T21:03:28.000Z","date":"2018-12-30","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares subject to this Form 4 were granted as part of a performance restricted stock unit granted May 31, 2017. All shares granted were forfeited as of March 13, 2018 due to the single performance milestone being deemed not achievable by the Company. This forfeiture was not previously reported to the Securities and Exchange Commission, as the number of shares was deemed immaterial by the issuer."}],"balance_after":53062,"source":{"system":"sec-edgar","filing":"0001013606-19-000022","document":"wf-form4_154648099216564.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000022/wf-form4_154648099216564.xml","form_type":"4"}},{"id":3911330,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-01T20:13:53.000Z","date":"2018-05-15","kind":"tax_withholding","acquired":false,"shares":10719,"price":4.87,"value":52201.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld on May 15, 2018 to satisfy statutory minimum tax withholding obligations related to shares vested on May 15, 2018."}],"balance_after":68692,"source":{"system":"sec-edgar","filing":"0001013606-18-000089","document":"wf-form4_152789841822583.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360618000089/wf-form4_152789841822583.xml","form_type":"4"}},{"id":3911329,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":89434,"kind":"person","name":"Thompson Matthew","position":1,"cik":"0001740988","reported_name":"Thompson Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-01T20:13:53.000Z","date":"2018-05-15","kind":"grant","acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award was originally granted on June 15, 2015. 100% of the shares subject to this restricted stock award vested pursuant to the terms of this award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total shares owned includes 4,488 shares purchased through the Company's Employee Stock Purchase Plan on April 30, 2018 and have not previously been disclosed due to immateriality."}],"balance_after":79411,"source":{"system":"sec-edgar","filing":"0001013606-18-000089","document":"wf-form4_152789841822583.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360618000089/wf-form4_152789841822583.xml","form_type":"4"}}]}